dihexa clinical trials or human studies dihexa human clinical trials or studies dihexa clinical trials status dihexa human trials status 2026 SCOPE dihexa clinical trials status Dihexa

In dermal fibroblast cultures, GHK-Cu has been shown to stimulate procollagen, glycosaminoglycan, and decorin synthesis, and has been characterized for antioxidant and anti-inflammatory effects in neuronal and macrophage cell models

For IBD specifically, KPV's evidence is more targeted and mechanism-specific than BPC-157's gut evidence

Neuroprotective Effects: Emerging research suggests that BPC-157 may offer protective benefits to the brain and nervous system, potentially aiding in recovery from neurological injuries

Long-acting amylin analog activating the amylin receptor complex (calcitonin receptor CALCR + receptor activity-modifying proteins RAMP1/2/3) via brainstem area postrema and hypothalamic circuits appetite suppression pathway distinct from GLP-1R